Company
Vivace Therapeutics
Transforming breakthrough biology into life-changing medicines for cancer patients
Also known as Vivace Therapeutics, Inc.
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Headquarters
- San Mateo, California, United States
- Legal name
- Vivace Therapeutics, Inc.
- vivacetherapeutics.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- Press page (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
Vivace Therapeutics is developing innovative cancer therapies with the goal of helping patients live longer, healthier lives.
Funding snapshot
- Total raised
- $60.5MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Undisclosed, $35M2025-03-12
Funding rounds
- Series D Financing
- $35M2025-03-12, Company stated
- Round, 2025
- $17.5M2025-02-28, SEC form D sold, 5 investors
- Round, 2020
- $30M2020-12-11, SEC form D sold, 6 investors
- Round, 2017
- $8M2017-05-05, SEC form D sold, 6 investors
- Round, 2015
- $5M2015-01-07, SEC form D sold, 3 investors
Loading relationship preview